{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:36:18Z","timestamp":1790796978152,"version":"4.1.0"},"reference-count":69,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"United Arab Emirates University","award":["#12R210"],"award-info":[{"award-number":["#12R210"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Liver fibrosis is associated with increased rates of morbidity and mortality. At present, there are no specific treatments that can directly reverse hepatic fibrosis. The endocannabinoid system has been found to play a significant role in regulating the development and progression of liver diseases, in addition to having protective effects. In this study, we investigate the protective potential of \u03b2-Caryophyllene (BCP) against Thioacetamide (TAA)-induced liver fibrosis. Wistar rats were injected with TAA (200 mg\/kg) three times per week for 8 weeks to induce liver fibrosis. They also received oral BCP before the TAA injections. AM630 (1 mg\/kg) was administered to confirm the CB2 receptor-dependent effect of BCP. The BCP treatment (50 mg\/kg) protected against cell injury and potentiated antioxidant defense by replenishing hepatic GSH, improving catalase activity, and inhibiting the formation of MDA. The co-administration of BCP mitigated the TAA-induced inflammatory response by decreasing the release of proinflammatory cytokines. Histological examination showed preserved cellular integrity, decreased collagen deposits with other extracellular matrix proteins, and low levels of myofibroblast activation. In addition, the BCP-treated rats demonstrated upregulated sirtuin 1 (SIRT1) expression, which had a direct inhibitory effect on hypoxia inducible factor (HIF-1\u03b1). AM630 pre-treatment inhibited all the aforementioned protective mechanisms of BCP. Based on our findings, BCP exerts protective effects in liver fibrosis, which can be attributed to its agonist action on CB2 receptors. This study provides preclinical evidence of the potential preventative benefits of BCP in liver fibrosis.<\/jats:p>","DOI":"10.3390\/ijms26178493","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:02:57Z","timestamp":1756825377000},"page":"8493","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u03b2-Caryophyllene Ameliorates Thioacetamide-Induced Liver Fibrosis in Rats: A Preventative Approach"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-8756","authenticated-orcid":false,"given":"Lujain","family":"Bader Eddin","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Mahgoub","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5147-0657","authenticated-orcid":false,"given":"Saeeda","family":"Almarzooqi","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1439-1562","authenticated-orcid":false,"given":"Ernest","family":"Adeghate","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4802-500X","authenticated-orcid":false,"given":"Sandeep B.","family":"Subramanya","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-2966","authenticated-orcid":false,"given":"Shreesh","family":"Ojha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates"},{"name":"Zayed Bin Sultan Center for Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1002\/wsbm.1499","article-title":"Liver fibrosis: Pathophysiology and clinical implications","volume":"13","author":"Berumen","year":"2021","journal-title":"WIREs Mech. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Acharya, P., Chouhan, K., Weiskirchen, S., and Weiskirchen, R. (2021). Cellular Mechanisms of Liver Fibrosis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.671640"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global Epidemiology of Chronic Liver Disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver diseases: Epidemiology, causes, trends and predictions","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prostaglandins.2013.02.002","article-title":"Endogenous cannabinoids revisited: A biochemistry perspective","volume":"102","author":"Fonseca","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","article-title":"An overview of the cannabinoid type 2 receptor system and its therapeutic potential","volume":"31","author":"Bie","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11427-013-4604-z","article-title":"Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart","volume":"57","author":"Wang","year":"2014","journal-title":"Sci. China Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/01902148.2018.1543368","article-title":"CB2R agonist prevents nicotine induced lung fibrosis","volume":"44","author":"Zarobkiewicz","year":"2018","journal-title":"Exp. Lung Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1089\/can.2021.0127","article-title":"Cannabinoid Type 2 Receptor Activation Reduces the Progression of Kidney Fibrosis Using a Mouse Model of Unilateral Ureteral Obstruction","volume":"7","author":"Swanson","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","article-title":"Antifibrogenic role of the cannabinoid receptor CB2 in the liver","volume":"128","author":"Julien","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13048-018-0478-9","article-title":"The role of the endocannabinoid system in female reproductive tissues","volume":"12","author":"Walker","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1476-5381.2011.01397.x","article-title":"The endocannabinoid system as a key mediator during liver diseases: New insights and therapeutic openings","volume":"163","author":"Mallat","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40261-020-00894-7","article-title":"Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases","volume":"40","author":"Cintosun","year":"2020","journal-title":"Clin. Drug Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/rheumatology\/kep189","article-title":"Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts","volume":"48","author":"Selvi","year":"2009","journal-title":"Rheumatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1096\/fj.09-129478","article-title":"The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia\/reperfusion-induced cardiomyopathy","volume":"23","author":"Defer","year":"2009","journal-title":"Faseb J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110876","DOI":"10.1016\/j.fct.2019.110876","article-title":"Dietary administration of \u03b2-caryophyllene and its epoxide to Sprague-Dawley rats for 90 days","volume":"135","author":"Bastaki","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Francomano, F., Caruso, A., Barbarossa, A., Fazio, A., La Torre, C., Ceramella, J., Mallamaci, R., Saturnino, C., Iacopetta, D., and Sinicropi, M.S. (2019). \u03b2-Caryophyllene: A Sesquiterpene with Countless Biological Properties. Appl. Sci., 9.","DOI":"10.3390\/app9245420"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S0007114512001298","article-title":"The antioxidant effect of \u03b2-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation","volume":"109","author":"Calleja","year":"2013","journal-title":"Br. J. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/bbb\/zbae129","article-title":"\u03b2-Caryophyllene, a dietary phytocannabinoid, alleviates high-fat diet-induced hepatic steatosis in mice via AMPK activation","volume":"88","author":"Kamikubo","year":"2024","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1293\/tox.2017-0018","article-title":"The effect of \u03b2-caryophyllene on nonalcoholic steatohepatitis","volume":"30","author":"Arizuka","year":"2017","journal-title":"J. Toxicol. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mazzantini, C., El Bourji, Z., Parisio, C., Davolio, P.L., Cocchi, A., Pellegrini-Giampietro, D.E., and Landucci, E. (2024). Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model. Pharmaceuticals, 17.","DOI":"10.3390\/ph17040467"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2014.08.021","article-title":"Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats","volume":"742","author":"Mahmoud","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"174910","DOI":"10.1016\/j.ejphar.2022.174910","article-title":"A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases","volume":"923","author":"Alshanwani","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"120040","DOI":"10.1016\/j.lfs.2021.120040","article-title":"Ingestion of mannose ameliorates thioacetamide-induced intrahepatic oxidative stress, inflammation and fibrosis in rats","volume":"286","author":"Shaker","year":"2021","journal-title":"Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Shin, M.R., Lee, J.A., Kim, M., Lee, S., Oh, M., Moon, J., Nam, J.W., Choi, H., Mun, Y.J., and Roh, S.S. (2021). Gardeniae Fructus Attenuates Thioacetamide-Induced Liver Fibrosis in Mice via Both AMPK\/SIRT1\/NF-\u03baB Pathway and Nrf2 Signaling. Antioxidants, 10.","DOI":"10.3390\/antiox10111837"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zhou, S., Gu, J., Liu, R., Wei, S., Wang, Q., Shen, H., Dai, Y., Zhou, H., Zhang, F., and Lu, L. (2018). Spermine Alleviates Acute Liver Injury by Inhibiting Liver-Resident Macrophage Pro-Inflammatory Response Through ATG5-Dependent Autophagy. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00948"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Abdel-Rahman, R.F., Fayed, H.M., Asaad, G.F., Ogaly, H.A., Hessin, A.F., Salama, A.A.A., Abd El-Rahman, S.S., Arbid, M.S., and Mohamed, M.A.E. (2021). The involvement of TGF-\u03b21 \/FAK\/\u03b1-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260130"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tsai, M.-Y., Yang, W.-C., Lin, C.-F., Wang, C.-M., Liu, H.-Y., Lin, C.-S., Lin, J.-W., Lin, W.-L., Lin, T.-C., and Fan, P.-S. (2021). The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice. Molecules, 26.","DOI":"10.3390\/molecules26071937"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Santacroce, G., Gentile, A., Soriano, S., Novelli, A., Lenti, M.V., and Di Sabatino, A. (2023). Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1124275"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"106556","DOI":"10.1016\/j.intimp.2020.106556","article-title":"\u03b2-Caryophyllene inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells","volume":"84","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Scandiffio, R., Geddo, F., Cottone, E., Querio, G., Antoniotti, S., Gallo, M.P., Maffei, M.E., and Bovolin, P. (2020). Protective Effects of (E)-\u03b2-Caryophyllene (BCP) in Chronic Inflammation. Nutrients, 12.","DOI":"10.3390\/nu12113273"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15376516.2023.2244061","article-title":"Serum \u03b1-SMA is a potential noninvasive biomarker of liver fibrosis","volume":"34","author":"Muriel","year":"2024","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.etp.2013.05.008","article-title":"Characterization of glial fibrillary acidic protein (GFAP)-expressing hepatic stellate cells and myofibroblasts in thioacetamide (TAA)-induced rat liver injury","volume":"65","author":"Tennakoon","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tox.2011.01.009","article-title":"\u03b1-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-\u03b2","volume":"282","author":"Foo","year":"2011","journal-title":"Toxicology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Selim, N.M., Melk, M.M., Melek, F.R., Saleh, D.O., Sobeh, M., and El-Hawary, S.S. (2022). Phytochemical profiling and anti-fibrotic activities of Plumbago indica L. and Plumbago auriculata Lam. in thioacetamide-induced liver fibrosis in rats. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-13718-9"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ibrahim, M.Y., Alamri, Z.Z., Juma, A.S.M., Hamood, S.A., Shareef, S.H., Abdulla, M.A., and Jayash, S.N. (2023). Hepatoprotective Effects of Biochanin A on Thioacetamide-Induced Liver Cirrhosis in Experimental Rats. Molecules, 28.","DOI":"10.3390\/molecules28227608"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","article-title":"Matrix metalloproteinases and liver fibrosis (translational aspects)","volume":"68","author":"Roeb","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ali, A.M., El-Tawil, O.S., Al-Mokaddem, A.K., and Abd El-Rahman, S.S. (2021). Promoted inhibition of TLR4\/miR-155\/ NF(k)B p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide. Chem. Biol. Interact., 336.","DOI":"10.1016\/j.cbi.2021.109398"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/liv.14863","article-title":"Role of fibroblast growth factor signalling in hepatic fibrosis","volume":"41","author":"Seitz","year":"2021","journal-title":"Liver Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1128\/MCB.18.10.6063","article-title":"FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation","volume":"18","author":"Hu","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1038\/s41467-023-42058-z","article-title":"Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis","volume":"14","author":"Tsuchiya","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-\u03b2\/SMAD Pathway and Its Regulation in Hepatic Fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J. Histochem. Cytochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"107155","DOI":"10.1016\/j.phrs.2024.107155","article-title":"SIRT1: Harnessing multiple pathways to hinder NAFLD","volume":"203","author":"Tian","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Yang, N., Sun, R., Zhang, X., Wang, J., Wang, L., Zhu, H., Yuan, M., Xu, Y., Ge, C., and He, J. (2023). Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT\/NAD+\/SIRT1 axis. Biomed. Pharmacother., 164.","DOI":"10.1016\/j.biopha.2023.114987"},{"key":"ref_51","first-page":"2783","article-title":"Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization","volume":"1863","author":"Cheng","year":"2017","journal-title":"Biochim. E Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"ElBaset, M.A., Salem, R.S., Ayman, F., Ayman, N., Shaban, N., Afifi, S.M., Esatbeyoglu, T., Abdelaziz, M., and Elalfy, Z.S. (2022). Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK\/SIRT-1\/HIF-1\u03b1 Pathway in Halting Liver Fibrosis. Antioxidants, 11.","DOI":"10.3390\/antiox11112152"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3390\/ijms14023834","article-title":"Crosstalk between Oxidative Stress and SIRT1: Impact on the Aging Process","volume":"14","author":"Salminen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7904845","DOI":"10.1155\/2022\/7904845","article-title":"The Potential Hepatoprotective Effect of Paeoniae Radix Alba in Thioacetamide-Induced Acute Liver Injury in Rats","volume":"2022","author":"Shin","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2013.05.108","article-title":"Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1\/PGC-1\u03b1 pathway","volume":"436","author":"Zheng","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1002\/jcp.27616","article-title":"Metformin inhibits mTOR\u2013HIF-1\u03b1 axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations","volume":"234","author":"Amin","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Mooli, R.G., Mukhi, D., Watt, M., Nagati, V., Reed, S.M., Gandhi, N.K., Oertel, M., and Ramakrishnan, S.K. (2024). Hypoxia-Inducible Factor-2\u03b1 Promotes Liver Fibrosis by Inducing Hepatocellular Death. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252313114"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jcmgh.2015.09.005","article-title":"Role of Hypoxia-Inducible Factors in the Development of Liver Fibrosis","volume":"1","author":"Roth","year":"2015","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, S., Qian, Q., Ying, N., Lai, J., Feng, L., Zheng, S., Jiang, F., Song, Q., Chai, H., and Dou, X. (2020). Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.560905"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Della Torre, S. (2021). Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. Cells, 10.","DOI":"10.3390\/cells10092502"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100870","DOI":"10.1016\/j.jhepr.2023.100870","article-title":"Sex differences in chronic liver disease and benign liver lesions","volume":"5","author":"Cooper","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2020.03.008","article-title":"Sex related differences in the pathogenesis of organ fibrosis","volume":"222","author":"Gonzalez","year":"2020","journal-title":"Transl. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"560345","DOI":"10.1155\/2012\/560345","article-title":"Establishment of a standardized liver fibrosis model with different pathological stages in rats","volume":"2012","author":"Li","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Yang, X.M., Wu, Z., Wang, X., Zhou, Y., Zhu, L., Li, D., Nie, H.Z., Wang, Y.H., Li, J., and Ma, X. (2022). Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability. BMC Pharmacol. Toxicol., 23.","DOI":"10.1186\/s40360-022-00583-5"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3748\/wjg.v8.i5.883","article-title":"Estrogen reduces CCL4-induced liver fibrosis in rats","volume":"8","author":"Xu","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"176165","DOI":"10.1016\/j.ejphar.2023.176165","article-title":"Estrogen\/estrogen receptor activation protects against DEN-induced liver fibrosis in female rats via modulating TLR-4\/NF-k\u03b2 signaling","volume":"960","author":"Eisa","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lee, Y.H., Son, J.Y., Kim, K.S., Park, Y.J., Kim, H.R., Park, J.H., Kim, K.-B., Lee, K.Y., Kang, K.W., and Kim, I.S. (2019). Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153709"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8493\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:37:19Z","timestamp":1760035039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":69,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178493"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178493","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}